Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Preferred Stock
Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   0 8,349      
Beginning balance at Dec. 31, 2020 $ 4,434 $ 0 $ 8 $ 204,376 $ (847) $ (199,103)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (3,670)         (3,670)
Issuance of common stock under:            
Equity financing, net (in shares)     3,980      
Equity financing, net 35,360   $ 4 35,356    
Exercise of warrants (in shares)     300      
Exercise of warrants 3,878   $ 1 3,877    
Matching contribution to 401(k) plan (in shares)     26      
Matching contribution to 401(k) plan 152     152    
Stock-based compensation expense 356     356    
Foreign currency translation adjustments 465       465  
Ending balance (in shares) at Mar. 31, 2021   0 12,655      
Ending balance at Mar. 31, 2021 40,975 $ 0 $ 13 244,117 (382) (202,773)
Beginning balance (in shares) at Dec. 31, 2020   0 8,349      
Beginning balance at Dec. 31, 2020 4,434 $ 0 $ 8 204,376 (847) (199,103)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (6,901)          
Issuance of common stock under:            
Matching contribution to 401(k) plan (in shares) 26          
Matching contribution to 401(k) plan $ 152          
Ending balance (in shares) at Sep. 30, 2021   0 12,664      
Ending balance at Sep. 30, 2021 39,062 $ 0 $ 13 245,299 (246) (206,004)
Beginning balance (in shares) at Mar. 31, 2021   0 12,655      
Beginning balance at Mar. 31, 2021 40,975 $ 0 $ 13 244,117 (382) (202,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (1,273)         (1,273)
Issuance of common stock under:            
Stock-based compensation expense 519     519    
Foreign currency translation adjustments (125)       (125)  
Ending balance (in shares) at Jun. 30, 2021   0 12,655      
Ending balance at Jun. 30, 2021 40,096 $ 0 $ 13 244,636 (507) (204,046)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (1,958)         (1,958)
Issuance of common stock under:            
Equity incentive plan (in shares)     9      
Stock-based compensation expense 663     663    
Foreign currency translation adjustments 261       261  
Ending balance (in shares) at Sep. 30, 2021   0 12,664      
Ending balance at Sep. 30, 2021 39,062 $ 0 $ 13 245,299 (246) (206,004)
Beginning balance (in shares) at Dec. 31, 2021   0 12,693      
Beginning balance at Dec. 31, 2021 37,219 $ 0 $ 13 246,090 (17) (208,867)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (4,620)         (4,620)
Issuance of common stock under:            
Matching contribution to 401(k) plan (in shares)     68      
Matching contribution to 401(k) plan 176     176    
Equity incentive plan (in shares)     83      
Stock-based compensation expense 499     499    
Foreign currency translation adjustments 212       212  
Ending balance (in shares) at Mar. 31, 2022   0 12,844      
Ending balance at Mar. 31, 2022 33,486 $ 0 $ 13 246,765 195 (213,487)
Beginning balance (in shares) at Dec. 31, 2021   0 12,693      
Beginning balance at Dec. 31, 2021 37,219 $ 0 $ 13 246,090 (17) (208,867)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (11,902)          
Issuance of common stock under:            
Matching contribution to 401(k) plan (in shares) 68          
Matching contribution to 401(k) plan $ 176          
Ending balance (in shares) at Sep. 30, 2022   0 13,127      
Ending balance at Sep. 30, 2022 28,614 $ 0 $ 13 247,884 1,486 (220,769)
Beginning balance (in shares) at Mar. 31, 2022   0 12,844      
Beginning balance at Mar. 31, 2022 33,486 $ 0 $ 13 246,765 195 (213,487)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (2,978)         (2,978)
Issuance of common stock under:            
Equity incentive plan (in shares)     166      
Stock-based compensation expense 582     582    
Foreign currency translation adjustments 639       639  
Ending balance (in shares) at Jun. 30, 2022   0 13,010      
Ending balance at Jun. 30, 2022 31,729 $ 0 $ 13 247,347 834 (216,465)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (4,304)         (4,304)
Issuance of common stock under:            
Equity incentive plan (in shares)     117      
Stock-based compensation expense 537     537    
Foreign currency translation adjustments 652       652  
Ending balance (in shares) at Sep. 30, 2022   0 13,127      
Ending balance at Sep. 30, 2022 $ 28,614 $ 0 $ 13 $ 247,884 $ 1,486 $ (220,769)